Non-invasive Vagus Nerve Stimulation in Patients Undergoing Electrophysiological Study

Description

The Non-invasive Vagus Nerve Stimulation in Patients Undergoing Electrophysiological Study is a single center, pilot, prospective study that aims at evaluating the effects of auricular vagus nerve stimulation (aVNS) on the human cardiac conduction system.

Conditions

Neuromodulation

Talk to us

Study Overview

On this page

Study Details

Study overview

The Non-invasive Vagus Nerve Stimulation in Patients Undergoing Electrophysiological Study is a single center, pilot, prospective study that aims at evaluating the effects of auricular vagus nerve stimulation (aVNS) on the human cardiac conduction system.

Non-invasive Vagus Nerve Stimulation in Patients Undergoing Electrophysiological Study (VNS-EPS)

Non-invasive Vagus Nerve Stimulation in Patients Undergoing Electrophysiological Study

Condition
Neuromodulation
Intervention / Treatment

-

Contacts and Locations

New York

Kristie Coleman, New York, New York, United States, 10075

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Primary indication for EPS for the evaluation of cardiac conduction system or supraventricular tachycardia.
  • * Previous EPS with ablation
  • * Previous failed ablation
  • * Known conduction system disease, right or left bundle branch block on EKG
  • * Pregnant women
  • * History of postural orthostatic tachycardia syndrome
  • * Patients who have had prior cervical vagotomy
  • * Patients with skin on the tragus that is broken or cracked
  • * Patients with a history of baseline cardiac disease or atherosclerotic cardiovascular disease, including congestive heart failure (CHF), known severe coronary artery disease or recent myocardial infarction (within 5 years) and patients diagnosed with narrowing of the arteries (carotid atherosclerosis)
  • * Patients with an active implantable medical device, such as a cardiac pacemaker, hearing aid implant, or any implanted metallic, implanted vagus nerve stimulator or electronic device.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Northwell Health,

Stavros E Mountantonakis, MD, PRINCIPAL_INVESTIGATOR, Northwell Health

Study Record Dates

2024-11-30